(Total Views: 432)
Posted On: 02/28/2018 4:32:56 PM
Post# of 2022
NetworkNewsBreaks – EVIO, Inc. (EVIO) Announces Aggressive Expansion Strategy that will Double its Cannabis Testing Facilities in 2018
This morning, EVIO, Inc. (OTCQB: EVIO), a leading cannabis testing company, announced its aggressive expansion strategy to double its number of accredited cannabis testing facilities from nine to 18 in 2018. In the press release, EVIO reported that the expansion will be spearheaded by two of its recently recruited team players. Albert Lustig will serve as the president, and Ron Russak will serve as the vice president of operations. According to EVIO CEO William Waldrop, Lustig will be instrumental in driving growth in both new and existing markets through the execution of the company’s national and international sales and operational strategies, and Russak, who brings with him 17 years of experience working with Quest Diagnostics, will focus on scaling EVIO’s new and existing testing facilities to boost growth and profitability. EVIO announced that the new cannabis testing laboratories will be spread across the five states in which it currently operates, with key focus on the $3.7 billion California cannabis market.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
This morning, EVIO, Inc. (OTCQB: EVIO), a leading cannabis testing company, announced its aggressive expansion strategy to double its number of accredited cannabis testing facilities from nine to 18 in 2018. In the press release, EVIO reported that the expansion will be spearheaded by two of its recently recruited team players. Albert Lustig will serve as the president, and Ron Russak will serve as the vice president of operations. According to EVIO CEO William Waldrop, Lustig will be instrumental in driving growth in both new and existing markets through the execution of the company’s national and international sales and operational strategies, and Russak, who brings with him 17 years of experience working with Quest Diagnostics, will focus on scaling EVIO’s new and existing testing facilities to boost growth and profitability. EVIO announced that the new cannabis testing laboratories will be spread across the five states in which it currently operates, with key focus on the $3.7 billion California cannabis market.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
